Continue with FacebookLooking to list your PhD opportunities? Log in here.
Cancer Biology PhD Projects, Programmes & Scholarships in the UK
We have 43 Cancer Biology PhD Projects, Programmes & Scholarships in the UK
We have 43 Cancer Biology PhD Projects, Programmes & Scholarships in the UK
PhD saved successfully
Development of Interventions for the Management of Fatigue in Primary Brain Tumour Patients
PhD Studentship on the Development of Interventions for the Management of Fatigue in Primary Brain Tumour Patients,. An opportunity to apply for a funded full-time PhD in the Faculty of Health and Applied Science, UWE Bristol. Read more
Molecular mechanisms of action and basis of resistance to hypomethylating agents in cancer
The student will be supervised by two supervisors. Prof Skirmantas Kriaucionis research group aims to elucidate the molecular function of DNA modifications in normal cells, leading to the understanding of how defective pathways contribute to the neoplasia. Read more
In situ analysis of the T-cell receptor repertoire in colorectal cancer
As cancer cells divide their DNA accumulates new mutations, some of which will lead to the generation of neoantigens – mutant peptides that can be recognised by immune cells as non-self. Specific (neo)antigen recognition is mediated by T cell receptors (TCRs), which are encoded by a hypervariable sequence that is unique to a TCR clone. Read more
PhD Studentship (3 years) In Vivo Diagnosis of Paediatric Brain Tumours using Multi-Modal Clinical MRI and Machine Learning
Applications are invited for a three-year Postgraduate studentship, supported by Help Harry Help Others (HHHO) and the College of Health and Life Sciences, to be undertaken within the Artificial Intelligence in Paediatric Neuroimaging (AIPNI) Research Group at Aston University. Read more
Using novel ferronucleosides to study and regulate DNA replication in cells
Background. Replication of nucleic acid polymers like DNA is an essential process for all known forms of life. Furthermore, dysregulation and errors in DNA-replication are strongly linked with human diseases including cancer, as well as the process of cellular ageing. Read more
Regulation of apoptosis-induced compensatory cell proliferation and its implications for cancer and tissue regeneration
In multi-cellular organisms, coordinated cell death (e.g. apoptosis) and cell replacement is critical for tissue recovery in response to stress or damage. Read more
Harnessing the bio-mechanical features of circulating tumour cells for their isolation in microfluidic devices
Cancer Research UK’s statistics suggest that individuals have over 40% likelihood of suffering from cancer during their life. Read more
Last chance to apply
Treating Cancer with CAR-T Therapy and Single Cell Transcriptomics
Oxford Brookes University. Faculty of Health and Life Sciences. Department of Biological and Medical Sciences, with Coding Bio Ltd. Read more
mRNA epigenetics: Charaterization of a novel layer of gene regulation for essential brain functions
Research Group:
BBSRC MIBTP
For over 40 years we know about modified nucleotides in mRNA, but the functions for these essential modifications are largely elusive. Read more
BBSRC MIBTP - Identification of pathways deregulating neuronal ELAV/Hu RNA binding proteins and alternative splicing in neurodegeneration
Research Group:
BBSRC MIBTP
ELAV/Hu proteins comprise a family of highly conserved neuronal RNA binding proteins important for the development of the nervous system and for neuronal functions. Read more
RNA Interference for Glioblastoma therapy using lipid nanoparticles
University of Central Lancashire Funded Doctoral Training Centre for Industry Collaboration. Inaugural PhD Studentships. The successful applicant will receive an annual stipend payment of £16062 and tuition fees will be covered. Read more
Functional characterisation of Siglec-15 as a new checkpoint inhibitor target
Tumours evolve many ways to gain survival advantage. New blood vessels are formed to deliver extra oxygen, nutrients and to assist mobilisation of… Read more
Last chance to apply
Exploiting metabolic vulnerabilities induced by dietary restriction as novel therapies for infant leukaemia
TO APPLY, CLICK 'INSTITUTION WEBSITE'. Infant leukaemia is an aggressive malignancy with cure rates of less than 50%. Importantly, despite large international trials, there has been no improvement in survival over the last 2 decades. Read more
Last chance to apply
Differential growth factor pathways in mesothelioma subtypes
TO APPLY CLICK 'INSTITUTION WEBSITE' . The genetic landscape of mesothelioma is dominated by loss of function mutations in various tumour suppressor genes (eg. Read more
Last chance to apply
Investigating the Role of Tertiary Lymphoid Structures in Tumour-Mediated Immunosuppression in pancreaticobiliary cancer employing spatial biology characterisation
TO APPLY CLICK 'INSTITUTION WEBSITE' . PDAC has one of the worst outcomes of any cancer, with a 5-year survival of less than 5%. Read more